Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Dalcetrapib

Dalcetrapib

Dalcetrapib structure

Dalcetrapib 

structure
  • CAS No:

    211513-37-0

  • Formula:

    C23H35NO2S

  • Chemical Name:

    Dalcetrapib

  • Synonyms:

    Propanethioic acid,2-methyl-,S-[2-[[[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino]phenyl] ester;JTT 705;Dalcetrapib

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Dalcetrapib (JTT-705; RO-4607381) is a rhCETP inhibitor with IC50 of 0.2 μM that increases the plasma HDL cholesterol. IC50 value: 0.2 uM [1]Target: CETPin vitro: Dalcetrapib modulates CETP activity. Dalcetrapib induces a conformational change in CETP, when added to human plasma. CETP-induced pre-β-HDL formation in human plasma is unchanged by Dalcetrapib ≤3 μM and increased at 10 μM. Dalcetrapib statistically and significantly increases pre-β-HDL formation [1]. Dalcetrapib achieves 50%

Dalcetrapib Basic Attributes

389.59

389.59

Characteristics

71.5

7.1

1.066 g/cm3

63-63.5 °C

273.676ºC

Safety Information

P273, P501

H413

Dalcetrapib Use and Manufacturing

Dalcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor. Dalcetrapib is a drug undergoing trials for the treatment of cardiovascular disease, dyslipidemia, peripheral arterial disease (PAD).

Recommended Suppliers of Dalcetrapib

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.